Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bicycle Therapeutics Limited

9.30
+0.22002.42%
Post-market: 9.300.00000.00%19:22 EDT
Volume:192.61K
Turnover:1.80M
Market Cap:643.58M
PE:-3.20
High:9.55
Open:9.44
Low:9.13
Close:9.08
Loading ...

Bicycle Therapeutics Price Target Maintained With a $29.00/Share by Needham

Dow Jones
·
Yesterday

RBC Cuts Price Target on Bicycle Therapeutics to $32 From $35, Keeps Outperform, Speculative Risk

MT Newswires Live
·
Yesterday

Bicycle Therapeutics Is Maintained at Overweight by Barclays

Dow Jones
·
Yesterday

Bicycle Therapeutics PLC reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
01 May

Bicycle Therapeutics Q1 EPS $(0.88) Misses $(0.86) Estimate, Collaboration Revenue $9.98M Beat $7.78M Estimate

Benzinga
·
01 May

Bicycle Therapeutics Unveils Investor Presentation Highlighting Innovative Medicines and Unique Peptide Platform

Reuters
·
01 May

Bicycle Therapeutics Reports First Quarter 2025 Results; Cash Reserves Drop to $793 Million Due to Increased Clinical Program Expenses

Reuters
·
01 May

Bicycle Therapeutics Plc: Expected Financial Runway Into 2H 2027

THOMSON REUTERS
·
01 May

Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results

THOMSON REUTERS
·
01 May

Bicycle Therapeutics Q1 Operating Incom USD -70.204 Million

THOMSON REUTERS
·
01 May

Bicycle Therapeutics Q1 Operating Expenses USD 80.181 Million

THOMSON REUTERS
·
01 May

Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results

Business Wire
·
01 May

BRIEF-Bicycle Therapeutics Announces Presentation Of Additional Human Radiopharmaceutical Imaging Data For Mt1-Mmp At The American Association For Cancer Research Annual Meeting 2025

Reuters
·
29 Apr

Bicycle Therapeutics Announces Presentation of Additional Human Radiopharmaceutical Imaging Data for Mt1-Mmp at the American Association for Cancer Research Annual Meeting 2025

THOMSON REUTERS
·
29 Apr

Bicycle Therapeutics Announces Presentation of Additional Human Radiopharmaceutical Imaging Data for MT1-MMP at the American Association for Cancer Research Annual Meeting 2025

Business Wire
·
29 Apr

Bicycle Therapeutics PLC expected to post a loss of 84 cents a share - Earnings Preview

Reuters
·
28 Apr

European Equities Traded in the US as American Depositary Receipts Rise Sharply in Tuesday Trading

MT Newswires Live
·
22 Apr

Bicycle Therapeutics Price Target Maintained With a $30.00/Share by Needham

Dow Jones
·
09 Apr

European Equities Traded in the US as American Depositary Receipts Tread Water in Tuesday Trading

MT Newswires Live
·
01 Apr

Bicycle Therapeutics Names Felix J. Baker as Chairman

MT Newswires Live
·
27 Mar